knowledge -WSS

knowledge

author：explore 2025-10-02 22:57:27 - browse：6966

Bernard Moss, a research scientist at NIAID. -- Infectious disease coverage from STAT — Bernard Moss Courtesy NIAID

For more than half a century, scientist Bernard Moss has been commanding the attention of peers interested in prying biological secrets from poxviruses and other microbiological targets. Now he’s commanding the attention of a different audience: House Republicans.

Moss, who will mark his 86th birthday in late July and who goes by Bernie, has worked for more than 55 years in the laboratories of the National Institute of Allergy and Infectious Diseases in Bethesda, Md. Over that time, he has been investigating viruses in relative anonymity — except, that is, among the virological cognoscenti.

But last year, in an interview with Science, Moss said he planned to try to determine why one strain of mpox viruses, known as Clade 1, is so much more virulent than those in a second strain, Clade 2, by taking genes from the former and putting them into the latter. Clade 2 viruses are responsible for the ongoing mpox outbreak first detected in May 2022.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Dobbs anniversary: the lost opportunity of abortion as health care
Next article： John Green on his newest strategy for fighting tuberculosis

WSS

Readout Newsletter: Bristol, Sangamo, Gilead, and more

Sweden knocks USA out of World Cup in penalty kicks

Flash flood warnings continue for parts of Missouri, Illinois

St. Louis police protesters begin picking up checks in $4.9 million settlement

Many breast cancer patients receive more radiation than needed

Boston's new lab space is opening empty

entertainment

knowledge

hotspot

State Dept. review finds Biden bears some blame for Afghanistan failures

Election results set back Medicaid expansion plans

New Eli Lilly Alzheimer’s data poses Medicare coverage conundrum

Democrats are overperforming in 2023's special elections. Is it a clue for Biden vs. Trump?

Activists slam private health insurers over coverage restrictions

Slovenia has suffered its worst

Jerome Adams on the need for new antivirals for Covid

Restaurant meals are packed with calories, and we still keep eating them

Novavax promises a turnaround & Lilly roils the obesity market

Change Healthcare outage fallout shows need for new oversight

hotspot

Why scientists need input from humanists on sensitive research

How many hemophilia patients actually want gene therapy?

Tuberculosis patients need more than just free medication

Ebola: Gilead Sciences antiviral shows promise as new treatment

Ebola: Gilead Sciences antiviral shows promise as new treatment

John Green on his newest strategy for fighting tuberculosis

hotspot

Wikipedia

leisure time

entertainment